Alternatives to Fluoxetine/Olanzapine (Symbyax) if You Can't Fill Your Prescription

Fluoxetine/Olanzapine (Symbyax) plays a unique role in psychiatry — it's one of only a handful of medications FDA-approved specifically for both bipolar I depression and treatment-resistant depression (TRD). But if you're unable to fill your prescription due to availability issues, cost concerns, or side effect problems, it helps to know your options.

This article outlines the main alternatives your doctor may consider, organized by the condition Symbyax is being used to treat. Always consult your prescriber before making any changes to your medication regimen.

First Option: Separate Fluoxetine and Olanzapine Prescriptions

Before exploring other drug alternatives, the simplest option when Symbyax is unavailable is to ask your prescriber for separate prescriptions for the two components: generic olanzapine (the active ingredient in Zyprexa) and generic fluoxetine (the active ingredient in Prozac). The FDA explicitly approves co-prescribing these as an alternative to the fixed-dose combination.

Both generics are inexpensive, widely available at nearly every pharmacy, and can be dosed to match your Symbyax prescription. Generic fluoxetine is as low as $4-$10 per month at many pharmacies, and generic olanzapine is typically $15-$40 per month. This is often significantly cheaper than the combination capsule.

Alternatives for Bipolar I Depression

If you are taking Fluoxetine/Olanzapine specifically for the depressive episodes of Bipolar I Disorder, these are other FDA-approved options your doctor may consider:

Quetiapine (Seroquel XR)

Quetiapine extended-release (Seroquel XR) is FDA-approved for bipolar I depression. It's an atypical antipsychotic that works as a monotherapy — no SSRI needed. It's often better tolerated for weight gain than olanzapine but can cause significant sedation. Generic quetiapine is widely available and relatively affordable. This is a common first alternative when Symbyax is unavailable.

Lurasidone (Latuda)

Lurasidone (Latuda) is FDA-approved for bipolar I depression in adults and children 10 and older — the same age range as Symbyax. It's generally considered weight-neutral, which is a significant advantage compared to olanzapine-containing regimens. It must be taken with food (at least 350 calories) for adequate absorption. Generic lurasidone became available in 2023, making it more affordable.

Cariprazine (Vraylar)

Cariprazine (Vraylar) is FDA-approved for bipolar I depression in adults. It's a partial dopamine/serotonin agonist with a unique mechanism compared to other atypical antipsychotics. It has a long half-life (allowing some flexibility in dosing), and clinical data suggests it may also have activating properties that can help with the low-energy aspects of bipolar depression.

Lamotrigine (Lamictal)

Lamotrigine (Lamictal) is a mood stabilizer FDA-approved for maintenance treatment of bipolar I disorder to delay depressive episodes. While not approved for acute bipolar depression, it is widely used off-label for this purpose and is recommended in clinical guidelines. Generic lamotrigine is extremely affordable. The main caveat is a slow titration schedule to reduce the risk of a serious rash.

Alternatives for Treatment-Resistant Depression (TRD)

If you are taking Fluoxetine/Olanzapine specifically for treatment-resistant depression (MDD that hasn't responded to two antidepressants), your doctor may consider:

Brexpiprazole (Rexulti)

Brexpiprazole (Rexulti) is FDA-approved as an adjunctive therapy for major depressive disorder — meaning it's added to an existing antidepressant, much like the olanzapine in Symbyax augments the fluoxetine. Rexulti tends to have a more favorable weight and metabolic profile than olanzapine.

Aripiprazole (Abilify)

Aripiprazole (Abilify) is FDA-approved as an adjunctive treatment for major depressive disorder. It's one of the most commonly used antidepressant augmentation agents. Generic aripiprazole is widely available and relatively affordable. Unlike olanzapine, aripiprazole tends to be weight-neutral or may even help with weight loss in some patients.

Esketamine (Spravato)

Esketamine (Spravato) is an FDA-approved nasal spray for treatment-resistant depression. It's a rapid-acting NMDA receptor antagonist — a completely different mechanism than Symbyax. Because it requires administration in a certified healthcare setting and monitoring for at least 2 hours afterward, it's typically reserved for patients who haven't responded to multiple oral medications.

Important: Always Consult Your Doctor Before Switching

This article is for informational purposes only. Never stop or switch psychiatric medications without guidance from your prescriber. Abrupt discontinuation of Fluoxetine/Olanzapine can cause discontinuation symptoms from the fluoxetine component and rebound symptoms from the olanzapine. Your doctor will guide any transition and ensure it's done safely.

Still Trying to Find Your Symbyax?

Before switching medications, it's worth exhausting your pharmacy options. medfinder.com can call pharmacies in your area to find which ones have Symbyax in stock, saving you hours of legwork. Check out our full guide to finding Fluoxetine/Olanzapine in stock for more strategies.